Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer
Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer
Active, not recruiting · NCT01273610 · Registry updated 2026-06-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2026-06-25 | NCT01273610 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| City of Hope Medical Center | 347 |
| GlaxoSmithKline | 294 |
| Novartis | 114 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Case Western Reserve University | Cleveland | United States | 219 |
| City of Hope Antelope Valley | Lancaster | United States | 52 |
| City of Hope Medical Center | Duarte | United States | 313 |
| Duke University Medical Center | Durham | United States | 1 |
| Lineberger Comprehensive Cancer Center, University of North Carolina | Chapel Hill | United States | 2 |
| Roswell Park Cancer Institute | Buffalo | United States | 382 |
| South Pasadena Cancer Center | Pasadena | United States | 1 |
| Thomas Jefferson University | Philadelphia | United States | 165 |